Latest Pravachol news
Pravastatin Does Not Improve Survival in Small-Cell Lung Cancer
posted March 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with small-cell lung cancer, addition of pravastatin to standard chemotherapy does not improve survival, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors Related Articles
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines Monthly Specialist Briefings
Stay Connected
